Analysis

A new survey finds widespread support for drug price reform to address the most significant threats to affordability.

As the election nears, here is a brief breakdown of what Trump has done — and has not done — on some key health issues.

More than 90% of respondents in a recent survey said they are not making changes to their pharmacy plan design because of COVID-19.

Economic growth since the mid-1970s hasn't benefited most American workers.

Among voters concerned about health care, however, Joe Biden has an edge.

Across all ages, most employees satisfied with core benefits but plan to consider voluntary offerings more carefully.